Chilton Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-48
| Closed | -$5K | – | 167 |
|
|
2016
Q2 | $5K | Hold |
48
| – | – | ﹤0.01% | 168 |
|
|
2016
Q1 | $5K | Hold |
48
| – | – | ﹤0.01% | 166 |
|
|
2015
Q4 | $9K | Hold |
48
| – | – | ﹤0.01% | 153 |
|
|
2015
Q3 | $8K | Hold |
48
| – | – | ﹤0.01% | 146 |
|
|
2015
Q2 | $30K | Hold |
48
| – | – | ﹤0.01% | 153 |
|
|
2015
Q1 | $25K | Hold |
48
| – | – | ﹤0.01% | 154 |
|
|
2014
Q4 | $26K | Hold |
48
| – | – | ﹤0.01% | 163 |
|
|
2014
Q3 | $71K | Hold |
48
| – | – | 0.01% | 156 |
|
|
2014
Q2 | $65K | Hold |
48
| – | – | 0.01% | 161 |
|
|
2014
Q1 | $66.1K | Hold |
48
| – | – | 0.01% | 158 |
|
|
2013
Q4 | $47.4K | Hold |
48
| – | – | 0.01% | 259 |
|
|
2013
Q3 | $49.6K | Hold |
48
| – | – | 0.01% | 253 |
|
|
2013
Q2 | $52K | Buy |
+48
| New | +$52K | 0.01% | 257 |
|